The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ellodi Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Ellodi Pharmaceuticals

Explore patent oppositions filed by Ellodi Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2886108
Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The EsophagusDR FALK PHARMANov 6, 2019
EP3086782
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The EsophagusDR FALK PHARMAJun 26, 2019

Latest patents of Ellodi Pharmaceuticals opposed by its competitors

Explore Ellodi Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3041476
Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis1
EP3403654
Jul 31, 2019Orally Administered Corticosteroid Compositions1
EP2482822
Aug 1, 2018Orally Administered Corticosteroid Compositions1

Latest PTAB cases involving Ellodi Pharmaceuticals

Discover the latest PTAB cases involving Ellodi Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ellodi Pharmaceuticals

PGR2025-00086Sep 19, 2025DR FALK PHARMAELLODI PHARMACEUTICALSPending
IPR2025-00052Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2025-00054Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2025-00055Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2025-00056Oct 24, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTrial Instituted
IPR2024-01197Jul 22, 2024DR FALK PHARMAELLODI PHARMACEUTICALS LPTerminated

Peer Comparison New

IP litigation analysis comparing Ellodi Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELLODI PHARMACEUTICALS23 - 1
DR FALK PHARMA1026 -